REG - MicroSalt PLC - Exercise of Stock Options and Total Voting Rights

MicroSaltAnnouncement

05/02/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250205:nRSE9217Va&default-theme=true

RNS Number : 9217V  MicroSalt PLC  05 February 2025

 

 

 

5 February 2025

 

MicroSalt plc

("MicroSalt®" or the "Company")

Exercise of Stock Options and Total Voting Rights

 

MicroSalt plc (AIM: SALT), a leading provider of full-flavour natural salt
with approximately 50% less sodium, announces that 165,591 ordinary shares of
£0.001625 each in the capital of the Company ("Ordinary Shares") ("Option
Shares") have been allotted to a shareholder to satisfy the exercise of
options over Ordinary Shares.

 

Options over an aggregate of 400,000 Ordinary Shares were exercised on a
cashless basis under an option agreement entered into in September 2023. Due
to the cashless basis of the exercise a total of 165,591 Option Shares were
allotted and issued. Pursuant to the terms of the option agreement, the
exercise price of each Option Share was US$0.545.

 

Application has been made to the London Stock Exchange for admission of the
Option Shares to trading on AIM ("Admission"). It is expected that Admission
will become effective on or around 7 February 2025.

 

Following the issue of the Option Shares, which on Admission will rank pari
passu with the existing Ordinary Shares, the total number of Ordinary Shares
in issue with voting rights in the Company will be 51,820,276. There are no
Ordinary Shares held in treasury.

 

The above figure of 51,820,276 may be used by shareholders in the Company as
the denominator for the calculations by which they will determine if they are
required to notify their interest in, or change to their interest in, the
share capital of the Company under the FCA's Disclosure Guidance and
Transparency Rules.

 

About MicroSalt plc

 

MicroSalt® is dedicated to innovating food technology solutions that enable
people to live longer, healthier, and happier lives. Its patented low-sodium
salt delivers natural salt with approximately 50% less sodium and may be used
by both consumers and food manufacturers to decrease the amount of sodium in
their food. SaltMe! chips are produced using MicroSalt®, a patented
innovative salt technology which is 100% natural, non-GMO, gluten free, and
Kosher certified, that does not contain any potassium chloride.

 

For more information, please visit www.microsaltinc.co
(http://www.microsaltinc.co) , follow on X @microSaltPLC or contact:

 

 MicroSalt plc                                                                                   Via Flagstaff PR
 Rick Guiney, CEO

 Flagstaff PR (Financial PR)                                                                     +44 (0)20 7129 1474
 Tim Thompson / Alison Allfrey / Anna Probert

 microsalt@flagstaffcomms.com

 Zeus (Nominated Adviser and                                                                     +44 (0)20 3829 5000
 Broker)

 David Foreman / James Edis (Investment Banking)

 Dom King (Corporate Broking), Rupert Woolfenden (Sales)

Notes to Editors

 

MicroSalt® produces a patented full-flavour, low-sodium salt for food
manufacturers and consumers.

 

MicroSalt is a major potential disruptor in the food market, thanks to its
micron-sized particles which deliver the same sense of saltiness to a wide
range of foods but with approximately 50% less sodium. Excess sodium
consumption is a significant contributor to cardiovascular disease and
MicroSalt's solution meets the rising demand for healthier alternatives to
traditional salt. The WHO has set a target for reducing global sodium intake
by 30% by 2025, which it estimates will save 7 million lives by 2030.

 

Each year, cardiovascular disease costs the UK £19 billion - if the
average salt intake was reduced by one gram per day, it has been estimated
that 4,147 lives and £288 million would be saved each year in the UK. As a
nation, the UK consumes 183 million kilograms of salt each year, and 70% of
the typical person's sodium intake is hidden in processed foods.

 

Operational since 2018, MicroSalt owns a patent-protected technology which we
believe helps create high barriers to entry within the reduced-sodium salt
market.

 

The Directors believe that MicroSalt is well positioned to capture growth in
the low sodium market, which is expected to grow exponentially, and that there
is also scope to enter the larger salt market.

 

MicroSalt has a three-pronged marketing strategy, targeting large B2B food
manufacturers, the B2C market and e-commerce customers. MicroSalt's all
natural, low-sodium solution is well positioned to take advantage of the
fast-growing market for a healthier alternative to traditional salt.

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPKQBPKBKBFBK